Primary Recipient

UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO

Amount

$5,227,290.00

Award Date

9/29/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The recent report that rapamycin increases the lifespan of mice is a major breakthrough in aging because it can be translated easily to humans. However, the critical question is whether long-term rapamycin treatment improves healthspan/quality-of-life as

Vendors Connected to Award

Vendor	Role	Amount
INVITROGEN CORPORATION	Primary vendor	$28,360.38
FISHER SCIENTIFIC	Primary vendor	$136,072.57
CELL SIGNALING TECHNOLOGY	Primary vendor	$26,168.80
BIO-RAD LABORATORIES	Primary vendor	$28,236.22
AB SCIEX LLC	Primary vendor	$30,258.59
LEICA MICROSYSTEMS INC	Primary vendor	$25,722.12